RE: Newsflow as expected15 Jun 2026 08:56
It'd be worth way, way more than a billion if successful at FDA stage - this is not your standard small time antibody it costs about 2 billion to get it to that stage - we'll need a big pocketed partner
DR5 is literally the holy grail of cancer antibodies